EarningsQ2 2024 Earnings Report

Astellas Pharma (4503N) Q2 2024 Earnings Report

1 Followers

MX:4503N Q2 2024 EPS Results

Actual EPS$2.28

Consensus EPS$2.05

Beat/MissBeat by +$0.23

One Year Ago EPS-$0.09

Actual Revenue$52.56B

Expected Revenue$48.57B

Beat/MissBeat by +$3.99B

YoY Revenue Growth+17.94%

QuarterQ2 2024

Date10/30/2024

TimeBefore Open

Conference CallWednesday, October 30, 2024

MX:4503N Upcoming Earnings

Astellas Pharma's next earnings date is estimated for November 4, 2026, based on past reporting schedules.

MX:4503N Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 04, 2026	2026 (Q2)	7.06 / -	5.025	―
Aug 05, 2026	2026 (Q1)	6.15 / 8.99	4.343	107.09% (+4.65)
Apr 27, 2026	2025 (Q4)	3.47 / 2.76	4.755	-41.95% (-1.99)
Feb 04, 2026	2025 (Q3)	5.22 / 6.37	-6.199	202.73% (+12.57)
Oct 30, 2025	2025 (Q2)	3.39 / 5.03	2.28	120.44% (+2.75)
Jul 30, 2025	2025 (Q1)	2.26 / 4.34	2.386	82.00% (+1.96)
Apr 25, 2025	2024 (Q4)	2.42 / 4.75	-2.109	325.50% (+6.86)
Feb 04, 2025	2024 (Q3)	2.79 / -6.20	1.182	-624.52% (-7.38)
Oct 30, 2024	2024 (Q2)	2.05 / 2.28	-0.091	2607.50% (+2.37)
Aug 01, 2024	2024 (Q1)	1.09 / 2.39	2.098	13.76% (+0.29)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed